Digital Repository

Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study

Show simple item record

dc.contributor.author Fernando, , M.M.P.S.C. en_US
dc.contributor.author Luke, W.A.N.V. en_US
dc.contributor.author Miththinda, J.K.N.D. en_US
dc.contributor.author Wickramasinghe, R.D.S.S. en_US
dc.contributor.author Sebastiampillai, B.S. en_US
dc.contributor.author Gunathilake, M.P.M.L. en_US
dc.contributor.author Silva, F.H. en_US
dc.contributor.author Premaratna, R. en_US
dc.date.accessioned 2017-07-04T09:43:44Z en_US
dc.date.available 2017-07-04T09:43:44Z en_US
dc.date.issued 2017 en_US
dc.identifier.citation BMC Infectious Diseases. 2017; 17(1): 138 en_US
dc.identifier.issn 1471-2334 (Electronic) en_US
dc.identifier.issn 1471-2334 (Linking) en_US
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/113 en_US
dc.description Indexed In MEDLINE en_US
dc.description.abstract BACKGROUND: Extended Spectrum Beta- Lactamase producing organisms causing urinary tract infections (ESBL-UTI) are increasing in incidence and pose a major burden to health care. While ESBL producing Klebsiella species seem to account for most nosocomial outbreaks, ESBL-producing E. coli have been isolated from both hospitalized and non-hospitalized patients. Although 95-100% ESBL organisms are still considered sensitive to meropenem, rapid emergence of carbapenem resistance has been documented in many countries. The objective of this study was to evaluate urinary tract infections caused by ESBL producers and the antibiotic susceptibility patterns in Sri Lanka. METHODS: Patients with confirmed ESBL-UTI admitted to Professorial Medical Unit, Colombo North Teaching Hospital from January - June 2015 were recruited to the study. Their urine culture and antibiotic susceptibility reports were evaluated after obtaining informed written consent. RESULTS: Of 61 culture positive ESBL-UTIs, E. coli caused 53 (86.8%), followed by Klebsiella in 8 (13.1%).30 (49.1%) had a history of hospitalization within the past three months and included 6/8(75%) of Klebsiella UTI and 24/53(45.2%) of E.coli UTI. Antibiotic susceptibility of ESBL organisms were; Meropenem 58 (95%), Imipenem 45 (73.7%), Amikacin 37 (60.6%) and Nitrofurantoin 28(45.9%). In 3(4.9%), E.coli were resistant to Meropenem. These three patients had received multiple antibiotics including meropenem in the recent past for recurrent UTI. CONCLUSIONS: We observed a higher percentage of E. coli over Klebsiella as ESBL producing organisms suggesting most ESBL-UTIs to be community acquired, Carbapenems seem to remain as the first line therapy for majority of ESBL-UTIs in the local setting. However 4.9% prevalence of meropenem resistance is alarming compared to other countries. Although prior antibiotic utilization and hospitalization may contribute to emergence of ESBL producing Klebsiella and E.coli in Sri Lanka, high prevalence of community acquired ESBL-E. coli needs further investigations to identify potential causes . Being a third world country with a free health care system, observed alarming rate of carbapenem resistance is likely to add a significant burden to health budget. We feel that treatment of infections in general needs a careful approach adhering to recommended antibiotic guidelines in order to prevent emergence of multi drug resistant organisms. en_US
dc.language.iso en_US en_US
dc.publisher BioMed Central en_US
dc.subject Carbapenem resistance en_US
dc.title Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account